After a presidential pardon earlier this year, Arthur Hayes, former CEO of BitMEX, has made an intriguing move – investing heavily in stem cell research. This shift signals […]
Ark Invest Bets Big on Fintech and Biotech Amid Market Correction
Investment firm Ark Invest, led by Cathie Wood, has taken advantage of the recent market correction to significantly shift its investment focus. During this period of volatility, Ark […]
BNB Treasury Strategy Fails: Biotech Firm Windtree Loses 77% After Nasdaq Delisting
Windtree Therapeutics, a biotechnology company that adopted a BNB treasury strategy last month, experienced a significant market downturn after being delisted from the Nasdaq. The company was notified […]
Klotho Neurosciences Stock Soars 787% After Gene Therapy Breakthrough
On June 9, 2025, Klotho Neurosciences Inc.’s stock experienced a dramatic surge of over 787%, following the company’s groundbreaking gene therapy research. The sudden increase reflects market excitement […]
Lyra Therapeutics Stock Soars 443% After Successful Phase 3 Trial
Lyra Therapeutics (NASDAQ: LYRA) shares experienced a dramatic surge of over 443%, reaching $26.81 in premarket trading following the announcement of successful results from its Phase 3 trial […]
DeSci Takes Center Stage: BIO SYNQ DAO Revolutionizes Biotech Innovation
The biotech industry is ripe for disruption, and DeSci is emerging as a powerful force behind this transformation. BIO SYNQ DAO takes the lead by harnessing decentralized technologies […]
NewLimit Raises $130 Million for Age Reversal Research, Capitalizing on Crypto Success
In a significant development bridging cryptocurrency’s impact with scientific innovation, NewLimit, a biotech venture co-founded by Coinbase CEO Brian Armstrong, has secured $130 million in funding. This investment […]
Brian Armstrong’s Venture Invests in Age Reversal Biotech with $130 Million Funding Round
Coinbase CEO Brian Armstrong has ventured into the world of biotech, supporting a company aiming to reverse the effects of aging. Through his startup, NewLimit, they’re developing treatments […]
YZi Labs Launches EASY Residence Program to Fuel Web3, AI & Biotech Innovation
YZi Labs has launched the EASY Residence Program in a global tech hub, providing dedicated support for startups focused on Web3, Artificial Intelligence (AI), and biotech innovation. Launching […]
Isomorphic Labs Secures $600M Funding: AI Revolutionizes Biotech Drug Discovery
Isomorphic Labs, a cutting-edge AI biotech company spun out from Google’s DeepMind, has secured a massive $600 million funding round. This unprecedented investment signals the transformative power of […]